Maneck M, Dotzenrath C, Dralle H, Fahlenbrach C, Paschke R, Steinmüller T, Tusch E, Jeschke E, Günster C
Wissenschaftliches Institut der AOK, Rosenthaler Str. 31, 10178, Berlin, Deutschland.
Klinik für Endokrine Chirurgie, Helios Universitätsklinikum Wuppertal, Wuppertal, Deutschland.
Chirurg. 2019 Mar;90(3):223-230. doi: 10.1007/s00104-018-0686-2.
This study investigated the frequency of postoperative speech therapy in the context of vocal cord palsy after thyroid surgery based on nationwide routine data. Additionally, volume-outcome relationships were examined.
Nationwide routine data from insured patients of the Local Health Insurance Fund (AOK) who underwent thyroid surgery for a benign thyroid disease between 2013 and 2015 were analyzed. Postoperative speech therapy was determined based on prescription data. Transient and permanent vocal cord palsy were determined using indicators. The effect of hospital volumes (volume quintiles) on prescription of postoperative speech therapy was determined by multivariate logistic regression.
A total of 50,676 thyroid gland operations were identified. The overall frequency of postoperative speech therapy prescription was 6.5%. In AOK patients with transient or permanent vocal cord palsy, the frequencies of postoperative speech therapy prescription were 56.1% and 75.2%, respectively. The prescription volume of the normal case (≥21 units of speech therapy) was exceeded in 0.7% of the AOK patients. In the two lowest case volume categories the risk of postoperative speech therapy exceeding the prescription volume of the normal case was significantly higher compared to the highest case volume hospitals (odds ratios: 1.2 and 1.8, respectively).
This study presents the reality of healthcare with respect to the frequency of speech therapy prescription after thyroid gland surgery in Germany. In addition, it was determined that the risk of postoperative speech therapy prescription exceeding the volume of the normal case after thyroid gland operations decreases with increasing case volumes of hospitals.
本研究基于全国常规数据,调查了甲状腺手术后声带麻痹情况下术后言语治疗的频率。此外,还研究了手术量与治疗效果之间的关系。
分析了2013年至2015年间因良性甲状腺疾病接受甲状腺手术的当地健康保险基金(AOK)参保患者的全国常规数据。根据处方数据确定术后言语治疗情况。使用指标确定暂时性和永久性声带麻痹。通过多因素逻辑回归确定医院手术量(手术量五分位数)对术后言语治疗处方的影响。
共识别出50676例甲状腺手术。术后言语治疗处方的总体频率为6.5%。在患有暂时性或永久性声带麻痹的AOK患者中,术后言语治疗处方的频率分别为56.1%和75.2%。0.7%的AOK患者术后言语治疗处方量超过正常病例(≥21次言语治疗)。与手术量最高的医院相比,手术量最低的两个类别中,术后言语治疗处方量超过正常病例的风险显著更高(优势比分别为1.2和1.8)。
本研究呈现了德国甲状腺手术后言语治疗处方频率方面的医疗实际情况。此外,研究还确定,随着医院手术量的增加,甲状腺手术后术后言语治疗处方量超过正常病例的风险会降低。